← Leaderboards
Mohamed H. Abdel-Rahman
Ohio State University
$3,602,822
Attributed
$3,602,822
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $602.6K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,602,822 · 3
By mechanism
R01$2,866,346 · 1
R21$736,476 · 2
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Tatiana M Oberyszyn$5,838,919
- Frederick H Davidorf$73,178
- Zhiwei Hu$584,703
- Pierre L Triozzi$2,848,907
- Hua Zhu$6,731,822
Others in their field
Top investigators on “Untranslated Regions”
- Manolis Kellis · Massachusetts Institute Of Technology$24,216,684
- Bing Ren · Ludwig Institute For Cancer Research$21,291,689
- Panagiotis Roussos · Icahn School Of Medicine At Mount Sinai$18,645,014
- Nenad Sestan · Yale University$18,340,124
- Michael P Snyder · Yale University$17,452,363
- Effie W Petersdorf · Fred Hutchinson Cancer Research Center$17,433,572
Research focus
Untranslated RegionsOnline Mendelian Inheritance In ManFamily MemberGenesPredispositionLeadPhenotypeSyndromeVariantCutaneous MelanomaMalignant NeoplasmsGerm-Line MutationInheritedClinical PhenotypeTumorMutationMesotheliomaRenal CarcinomaHigh RiskGeneral PopulationCohortCodeGeneticPathogenesis
Grant awards (9)
Spectrum of clinical phenotype of the BAP1-tumor predisposition syndrome (BAP1-TPDS)$602,616
R01 · FY2025 · CA · contact PI
Spectrum of clinical phenotype of the BAP1-tumor predisposition syndrome (BAP1-TPDS)$583,603
R01 · FY2024 · CA · contact PI
Spectrum of clinical phenotype of the BAP1-tumor predisposition syndrome (BAP1-TPDS)$550,328
R01 · FY2023 · CA · contact PI
Spectrum of clinical phenotype of the BAP1-tumor predisposition syndrome (BAP1-TPDS)$548,672
R01 · FY2022 · CA · contact PI
Spectrum of clinical phenotype of the BAP1-tumor predisposition syndrome (BAP1-TPDS)$581,127
R01 · FY2021 · CA · contact PI
Evaluation of an OCA2 enhancer variant as a modifier of the phenotype of BAP1-Tumor predisposition syndrome$164,560
R21 · FY2019 · CA · contact PI
Evaluation of an OCA2 enhancer variant as a modifier of the phenotype of BAP1-Tumor predisposition syndrome$203,471
R21 · FY2018 · CA · contact PI
Hereditary cancer predisposition syndromes and uveal melanoma$167,475
R21 · FY2016 · CA · contact PI
Hereditary cancer predisposition syndromes and uveal melanoma$200,970
R21 · FY2015 · CA · contact PI